IRIS
BARBANTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.692
AS - Asia 12.052
EU - Europa 9.176
SA - Sud America 1.778
Continente sconosciuto - Info sul continente non disponibili 510
AF - Africa 175
OC - Oceania 16
Totale 40.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.404
HK - Hong Kong 7.931
IE - Irlanda 5.963
SG - Singapore 2.235
BR - Brasile 1.454
GB - Regno Unito 946
IT - Italia 620
CN - Cina 491
CH - Svizzera 413
VN - Vietnam 395
FI - Finlandia 331
BD - Bangladesh 286
DE - Germania 248
TR - Turchia 160
RU - Federazione Russa 131
AR - Argentina 124
IN - India 113
FR - Francia 108
CA - Canada 107
MX - Messico 85
SE - Svezia 82
IL - Israele 62
NL - Olanda 62
EC - Ecuador 56
IQ - Iraq 52
PL - Polonia 51
CO - Colombia 48
EE - Estonia 41
ID - Indonesia 41
ZA - Sudafrica 38
CZ - Repubblica Ceca 36
PK - Pakistan 34
UZ - Uzbekistan 33
ES - Italia 32
KR - Corea 28
SC - Seychelles 27
AT - Austria 26
JP - Giappone 25
MA - Marocco 25
PY - Paraguay 23
UA - Ucraina 23
EG - Egitto 20
PH - Filippine 20
VE - Venezuela 20
CL - Cile 19
CR - Costa Rica 19
UY - Uruguay 19
KE - Kenya 17
JM - Giamaica 15
SA - Arabia Saudita 15
AU - Australia 14
MY - Malesia 14
AE - Emirati Arabi Uniti 12
TT - Trinidad e Tobago 12
IR - Iran 11
JO - Giordania 11
NP - Nepal 11
ET - Etiopia 10
PE - Perù 10
TN - Tunisia 10
AZ - Azerbaigian 9
BB - Barbados 9
TH - Thailandia 9
BG - Bulgaria 8
DZ - Algeria 8
TW - Taiwan 8
AM - Armenia 7
GT - Guatemala 7
KZ - Kazakistan 7
LT - Lituania 7
NI - Nicaragua 7
HN - Honduras 6
LV - Lettonia 6
BO - Bolivia 5
LY - Libia 5
OM - Oman 5
AL - Albania 4
AO - Angola 4
BE - Belgio 4
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KG - Kirghizistan 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
GP - Guadalupe 3
HU - Ungheria 3
LB - Libano 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
TG - Togo 3
UG - Uganda 3
GD - Grenada 2
Totale 39.864
Salva come PNG Salva come JPEG
Città #
Hong Kong 7.929
Dallas 6.309
Dublin 5.922
Ashburn 1.699
San Jose 1.597
Singapore 1.078
London 836
Boardman 807
Santa Clara 530
The Dalles 481
Chicago 478
Zurich 406
Council Bluffs 327
Helsinki 318
Washington 199
Phoenix 195
Los Angeles 145
Ho Chi Minh City 138
São Paulo 127
New York 119
Istanbul 115
Beijing 110
Hanoi 87
Assago 76
Munich 73
Milan 61
Rome 56
Rio de Janeiro 54
San Francisco 53
Warsaw 43
Hillsboro 42
Belo Horizonte 38
Catania 38
Orem 37
Brooklyn 36
Frankfurt am Main 36
North Bergen 35
Seattle 34
Montreal 33
Mexico City 32
Amsterdam 29
Tashkent 28
Chennai 27
Brasília 26
Atlanta 25
Seoul 25
Boston 23
Buffalo 23
Guayaquil 23
Bemidji 22
Porto Alegre 22
Brno 21
Naples 21
Salvador 20
Johannesburg 18
Montevideo 18
Stockholm 18
Curitiba 17
Manchester 17
Shanghai 17
Da Nang 16
Haiphong 16
Miami 16
Mumbai 16
Nairobi 16
Quito 16
Hải Dương 15
Campinas 14
Olomouc 14
Tokyo 14
Dhaka 13
Falkenstein 13
Toronto 13
Buenos Aires 12
Duque de Caxias 12
Goiânia 12
Guarulhos 12
Thái Bình 12
Turin 12
Abbeville 11
Amman 11
Baghdad 11
Cipolletti 11
Fortaleza 11
Philadelphia 11
Queens 11
Bari 10
Clifton 10
Genoa 10
Kingston 10
Piscataway 10
Reston 10
Ribeirão Preto 10
San José 10
Thái Nguyên 10
Turku 10
Addis Ababa 9
Bexley 9
Bologna 9
Bridgetown 9
Totale 31.646
Salva come PNG Salva come JPEG
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.479
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.183
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 977
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 975
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 727
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 663
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 590
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 576
Predicting neocommissural orientation during TAVI workup 514
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 501
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 452
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 399
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 384
Le nuove frontiere della cardiologia interventistica strutturale 364
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 153
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 152
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 147
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 147
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 142
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 141
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 137
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 136
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 131
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 131
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 131
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 131
Transcatheter mitral valve implantation: CardiAQ 124
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 119
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 118
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 118
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 116
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 115
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 114
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 113
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 113
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 113
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 113
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 110
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 108
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 105
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 105
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 104
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 104
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 104
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 104
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 103
Managing complications after transcatheter aortic valve implantation 102
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 102
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 102
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 101
Early detection of transcatheter heart valve dysfunction 100
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 100
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 99
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 99
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 98
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 97
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 97
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 97
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 97
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 96
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 95
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 95
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 94
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 94
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 93
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 93
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 93
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 92
The Helio transcatheter aortic dock for patients with aortic regurgitation 92
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 92
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 92
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 92
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 92
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 92
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 91
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 91
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 91
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 91
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 90
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 90
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 90
Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management 90
Cerebral embolization during transcatheter aortic valve implantation 89
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 89
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 89
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 89
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 89
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 88
Bioprosthetic valves for transcatheter aortic valve replacement 88
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 88
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 88
Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves 88
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 87
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 87
Severe aortic valve stenosis: Symptoms, biochemical markers, and global longitudinal strain 87
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 86
Management of severe stenosis controversies and promises 86
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 86
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 85
Perivalvular Extension of Infective Endocarditis After Transcatheter Aortic Valve Replacement 85
Totale 19.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/202614.972 870 3.391 3.663 1.212 323 469 1.512 975 991 848 420 298
2026/20272.202 224 326 465 1.088 99 0 0 0 0 0 0 0
Totale 40.399